[ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION].
D000285:Administration, Rectal; D000286:Administration, Sublingual; D004358:Drug Therapy; D006493:Heparin; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*; D008071:Lipoprotein Lipase; D010600:Pharmacology; D011188:Potassium; D012964:Sodium; D012982:Sodium, Dietary; D013488:Suppositories
D000960:Hypolipidemic Agents; D008055:Lipids; D012982:Sodium, Dietary; D013488:Suppositories; D006493:Heparin; D012964:Sodium; D008071:Lipoprotein Lipase; D011188:Potassium
BLOOD LIPIDS; DRUG THERAPY; HEPARIN; LIPOPROTEIN LIPASE; PHARMACOLOGY; POTASSIUM; SODIUM; SUPPOSITORIES
ANTILIPAEMISCHE WIRKUNG VON SAUREM NATRIUM-HEPARIN BEI SUBLINGUALER ODER RECTALER VERABREICHUNG.